Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.51% sank 0.17% to $72.25 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.47% rising 0.28% to 4,726.35 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% rising 0.11% to 36,290.32. The stock's fall snapped a two-day winning streak. Gilead Sciences Inc. closed $1.87 short of its 52-week high ($74.12), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.91% fell 0.85% to $169.79, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.83% fell 0.58% to $81.20, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.38% rose 0.23% to $137.29. Trading volume (7.2 M) eclipsed its 50-day average volume of 7.1 M.